Short answer
Ardent Health, Inc. (ARDT) filed an 8-K current report with the SEC on August 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Reg FD liability protection language; no operating results included in the provided excerpt.
Ardent Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Reg FD liability protection language; no operating results included in the provided excerpt
- No revenue, earnings, guidance, or fiscal-year 2026 performance figures available for investor assessment
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $1.62B, down 1.4% YoY, reflecting lower reimbursement and delayed New Mexico payment benefits
- Net income fell to $17M from $73M, while adjusted EBITDA declined 32.3% to $115M
- Adjusted admissions grew 2.5%, but total surgeries decreased 2.9%, including inpatient surgeries down 7.5%
- Operating cash flow rose 67% to $197M, supporting liquidity of $992M and net leverage of 0.8x
- 2026 guidance reaffirmed: revenue $6.4B–$6.7B and adjusted EBITDA $485M–$535M; IMPACT savings target increased to at least $70M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Ardent Health, Inc. 8-K filings
Get the next ARDT 8-K as it lands
Follow ARDT for push alerts, or ask the research agent what this filing means.